Lipoprotein-Associated Proteins Involved in Platelet Signaling
Authors:
- Suzanne J.A. KorporaalSKSuzanne J.A. Korporaal
- Jan-Willem N. AkkermanJAJan-Willem N. Akkerman
- 1 July 2006
- journal article
- review article
- Published by S. Karger AG in Pathophysiology of Haemostasis and Thrombosis
- Vol. 35 (3-4) , 305-313
Abstract
Platelets and lipoproteins are both key elements in the development of atherosclerosis and thrombosis. Based on their density, five classes of lipoproteins have been identified which all influence platelets via distinct mechanisms. The activation of platelets starts with binding of apolipoproteins to different platelet receptors and is followed by the activation of signaling pathways resulting in activation or inhibition of platelet functions like aggregation or secretion. In addition to apolipoproteins, lipoproteins are also associated to a large amount of proteins, enzymes and lipids that also can induce platelet activation or inhibition. This review provides a summary of the activation of signaling pathways after platelet–lipoprotein interactions initiated by lipoprotein-associated proteins and lipids.Keywords
This publication has 4 references indexed in Scilit:
- Genetic and Pharmacological Analyses of Syk Function in IIbβ3 Signaling in PlateletsBlood, 1999
- Circulating tumor gangliosides enhance platelet activationBlood, 1994
- Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitorBlood, 1991
- Interaction of lipoteichoic acid of group A streptococci with human plateletsInfection and Immunity, 1977